Weave Bio Therapeutics
- Biotech or pharma, therapeutic R&D
- Medical device or technology
WeaveBio Therapeutics is pioneering transformative silk-based scaffolds designed for the regeneration of hollow organs, addressing significant unmet needs in regenerative medicine. Utilizing proprietary silk scaffold technology originally developed at a leading Boston-based university by founders renowned in their field, WeaveBio targets conditions such as urethral strictures and pediatric hypospadias, where current standards rely heavily on invasive autologous grafts with suboptimal outcomes. The bioresorbable silk scaffolds support natural tissue regeneration, offering superior biocompatibility, reduced complications, and improved patient outcomes. Recently strengthened through strategic asset acquisition of pre-IDE enabling data, WeaveBio is raising $11M Ser A to facilitate technology transfer and GMP production, further de-risk preclinical pipeline indications and advance clinical validation for the lead indication.
Address
CambridgeMassachusetts
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}